Prevalence and Clinical Characteristics of Patients With Jackhammer Esophagus and Symptoms of Gastroesophageal Reflux Disease
1 other identifier
observational
37
0 countries
N/A
Brief Summary
Gastroesophageal reflux disease (GERD) is involved in the development of esophageal motility disorders like Jackhammer esophagus (JE), a novel hypercontractile condition that was associated with progression to achalasia and limited outcomes following surgical anti-reflux therapy. This trial was designed to assess the prevalence and characteristics of JE in patients with typical symptoms of GERD and responsiveness to PPI therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2014
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2017
CompletedFirst Submitted
Initial submission to the registry
November 15, 2017
CompletedFirst Posted
Study publicly available on registry
November 20, 2017
CompletedNovember 21, 2017
November 1, 2017
3.4 years
November 15, 2017
November 18, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of Jackhammer esophagus in patients referred with symptoms of gastroesophageal reflux disease
All patients that are referred to our center with symptoms of gastroesophageal reflux disease routinely undergo high-resolution manometry. We assess how many patients are diagnosed with Jackhammer esophagus
January 2014- May 2017
Secondary Outcomes (2)
Symptom perception
January 2014- May 2017
Prevalence of gastroesophageal reflux disease in patients with Jackhammer esophagus
Januar 2014- May 2017
Eligibility Criteria
All patients that are referred to our center undergo esophageal high-resolution manometry and ambulatory pH monitoring for screening of gastroesophageal reflux disease and motility disorders. We assess the data that are prospectively obtained. Patients do not have to undergo any interventions.
You may qualify if:
- Patients with symptoms of gastroesophageal reflux disease and diagnosis of Jackhammer esophagus
You may not qualify if:
- patients not willing to participate data or undergo screening for gastroesophageal reflux disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Kristo I, Schwameis K, Maschke S, Kainz A, Rieder E, Paireder M, Jomrich G, Schoppmann SF. Phenotypes of Jackhammer esophagus in patients with typical symptoms of gastroesophageal reflux disease responsive to proton pump inhibitors. Sci Rep. 2018 Jul 2;8(1):9949. doi: 10.1038/s41598-018-27756-9.
PMID: 29967357DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sebastian Schoppmann, MD
Vice Chair of Department of General Surgery
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. med. univ.
Study Record Dates
First Submitted
November 15, 2017
First Posted
November 20, 2017
Study Start
January 1, 2014
Primary Completion
May 30, 2017
Study Completion
May 30, 2017
Last Updated
November 21, 2017
Record last verified: 2017-11